Drug Interactions between Dvorah and methylene blue
This report displays the potential drug interactions for the following 2 drugs:
- Dvorah (acetaminophen/caffeine/dihydrocodeine)
- methylene blue
Interactions between your drugs
methylene blue dihydrocodeine
Applies to: methylene blue and Dvorah (acetaminophen / caffeine / dihydrocodeine)
Using dihydrocodeine together with methylene blue may rarely increase the risk of serious side effects such as respiratory depression, low blood pressure, fainting, coma, and even death. In general, it is best to wait at least 14 days after stopping methylene blue before you start treatment with dihydrocodeine. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should avoid the use of alcohol while being treated with these medications. Also avoid driving or operating hazardous machinery until you know how your medications affect you, and do not exceed the dosage or frequency of use prescribed by your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
Applies to: Dvorah (acetaminophen / caffeine / dihydrocodeine)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.